A novel embryonic poly(A) binding protein
一种新型胚胎多聚腺苷酸结合蛋白
基本信息
- 批准号:6602242
- 负责人:
- 金额:$ 7.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-06-01 至 2005-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Our ultimate goal is to understand the mechanisms by which maternally stored molecules control the earliest stages of vertebrate development. In particular, we are interested in the mechanisms that control the translational activation of stored maternal mRNAs during oocyte maturation and embryonic development prior to zygotic transcription. The translation of many stored maternal mRNAs is activated when their 3' poly (A) tails are elongated in a specific and developmentally regulated poly (A) addition reaction that takes place in the cytoplasm. This application is concerned with the regulated addition of poly (A) tails to maternal mRNAs that occurs during projesterone-induced oocyte maturation of the frog, Xenopus laevis. Specifically, we propose that a novel poly (A) tail binding protein that we have identified and named embryonic PABII (ePABII) is required for the selective 3' poly (A) elongation of particular maternal mRNAs during oocyte maturation. The developmental expression pattern of ePABII and its cytoplasmic location provide compelling circumstantial evidence that ePABII is involved in the dynamic mRNA poly (A) tail changes that occur during oocyte maturation and the maternal stages of development. This RO3 application describes several types of experiments designed to test directly the potential functional role of ePABII in maturation-specific mRNA poly (A) tail changes. Data from these initial experiments will provide the preliminary evidence critical for a more comprehensive RO1 grant that will focus on the mechanistic role of ePABII in the maternally controlled development of Xenopus laevis and other vertebrates.
描述(由申请人提供):我们的最终目标是了解母体储存的分子控制脊椎动物发育最早阶段的机制。我们特别感兴趣的是在合子转录之前的卵母细胞成熟和胚胎发育过程中控制储存的母体 mRNA 翻译激活的机制。当许多储存的母体 mRNA 的 3' 聚 (A) 尾在细胞质中发生的特定且发育调节的聚 (A) 加成反应中延长时,它们的翻译就会被激活。该应用涉及在孕酮诱导的非洲爪蟾卵母细胞成熟过程中向母体 mRNA 中调节多聚 (A) 尾的添加。具体来说,我们提出,我们已经鉴定并命名为胚胎 PABII (ePABII) 的新型聚 (A) 尾结合蛋白是卵母细胞成熟过程中特定母体 mRNA 选择性 3' 聚 (A) 延伸所必需的。 ePABII 的发育表达模式及其细胞质位置提供了令人信服的间接证据,表明 ePABII 参与卵母细胞成熟和母体发育阶段发生的动态 mRNA 聚 (A) 尾变化。该 RO3 应用描述了几种类型的实验,旨在直接测试 ePABII 在成熟特异性 mRNA 聚 (A) 尾变化中的潜在功能作用。这些初步实验的数据将为更全面的 RO1 拨款提供至关重要的初步证据,该拨款将重点关注 ePABII 在非洲爪蟾和其他脊椎动物母体控制发育中的机制作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael D Sheets其他文献
Michael D Sheets的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael D Sheets', 18)}}的其他基金
Regulation of cell fates by the Bicaudal-C translational repressor
Bicaudal-C 翻译阻遏蛋白对细胞命运的调节
- 批准号:
10161800 - 财政年份:2018
- 资助金额:
$ 7.05万 - 项目类别:
Regulation of cell fates by the Bicaudal-C translational repressor
Bicaudal-C 翻译阻遏蛋白对细胞命运的调节
- 批准号:
10407579 - 财政年份:2018
- 资助金额:
$ 7.05万 - 项目类别:
Regulation of cell fates by the Bicaudal-C translational repressor
Bicaudal-C 翻译阻遏蛋白对细胞命运的调节
- 批准号:
9523681 - 财政年份:2018
- 资助金额:
$ 7.05万 - 项目类别:
Regulation of cell fates by the Bicaudal-C translational repressor
Bicaudal-C 翻译阻遏蛋白对细胞命运的调节
- 批准号:
9922709 - 财政年份:2018
- 资助金额:
$ 7.05万 - 项目类别:
Regulation of cell fates by the Bicaudal-C translational repressor
Bicaudal-C 翻译阻遏蛋白对细胞命运的调节
- 批准号:
9756193 - 财政年份:2018
- 资助金额:
$ 7.05万 - 项目类别:
Enabling Xenopus oocytes and embryos to perform RNAi
使非洲爪蟾卵母细胞和胚胎能够进行 RNAi
- 批准号:
8339842 - 财政年份:2012
- 资助金额:
$ 7.05万 - 项目类别:
Enabling Xenopus oocytes and embryos to perform RNAi
使非洲爪蟾卵母细胞和胚胎能够进行 RNAi
- 批准号:
8533803 - 财政年份:2012
- 资助金额:
$ 7.05万 - 项目类别:
相似海外基金
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 7.05万 - 项目类别:
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
- 批准号:
EP/Y024540/1 - 财政年份:2024
- 资助金额:
$ 7.05万 - 项目类别:
Fellowship
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
- 批准号:
MR/Y008847/1 - 财政年份:2024
- 资助金额:
$ 7.05万 - 项目类别:
Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
- 批准号:
BB/Y002180/1 - 财政年份:2024
- 资助金额:
$ 7.05万 - 项目类别:
Research Grant
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 7.05万 - 项目类别:
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 7.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
- 批准号:
MR/Y003616/1 - 财政年份:2024
- 资助金额:
$ 7.05万 - 项目类别:
Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
- 批准号:
MR/Y033698/1 - 财政年份:2024
- 资助金额:
$ 7.05万 - 项目类别:
Research Grant
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
- 批准号:
23H03716 - 财政年份:2023
- 资助金额:
$ 7.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis research of anti-Sez6l2 antibody associated encephalopathy
抗Sez6l2抗体相关脑病的分析研究
- 批准号:
23K06940 - 财政年份:2023
- 资助金额:
$ 7.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




